Argentina Viscosupplementation Market Size & Outlook
Argentina viscosupplementation market, 2018-2030 (US$M)
Related Markets
Argentina viscosupplementation market highlights
- The Argentina viscosupplementation market generated a revenue of USD 9.2 million in 2023 and is expected to reach USD 18.5 million by 2030.
- The Argentina market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, three injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 9.2 million |
| Market revenue in 2030 | USD 18.5 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Three injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.2% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 18.5 million by 2030.
Three injection was the largest segment with a revenue share of 43.48% in 2023. Horizon Databook has segmented the Argentina viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
Osteoarthritis is a common joint disease in Argentina, which is characterized by joint degeneration arising due to various factors. In a study conducted in Argentina, it has been found that 1.6 million individuals suffer from knee osteoarthritis, and around 1 million suffers from hip osteoarthritis. Their clinical indications include function loss, pain, and disability.
Conventional treatment options are used to reduce symptoms, and by decreasing the disability. Traditional pharmacological treatment such as intra-articular corticoids are widely used in the country but viscosupplementation via hyaluronic acid-based products seems to gain its popularity with its efficacy and more sustained effect with time.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina viscosupplementation market size, by product, 2018-2030 (US$M)
Argentina Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
